BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18039530)

  • 1. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New targets for non-small-cell lung cancer therapy.
    Alvarez M; Roman E; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma.
    Sanlioglu AD; Aydin C; Bozcuk H; Terzioglu E; Sanlioglu S
    Lung Cancer; 2004 May; 44(2):199-211. PubMed ID: 15084385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular oncology--perspectives in lung cancer.
    Huber RM; Stratakis DF
    Lung Cancer; 2004 Aug; 45 Suppl 2():S209-13. PubMed ID: 15552801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and management of malignant pleural mesothelioma.
    Zucali PA; Giaccone G
    Eur J Cancer; 2006 Nov; 42(16):2706-14. PubMed ID: 16989994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational therapies for malignant pleural mesothelioma.
    Belli C; Anand S; Tassi G; Fennell D; Mutti L
    Expert Rev Respir Med; 2010 Apr; 4(2):249-60. PubMed ID: 20406091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular therapy targets in lung cancer].
    Le Guen Y; Sabatier L; Le Chevalier T; Soria JC
    Bull Cancer; 2003 Dec; 90(12):1055-61. PubMed ID: 14715425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced NSCLC: from cytotoxic systemic chemotherapy to molecularly targeted therapy.
    Hoang T; Schiller JH
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):393-401. PubMed ID: 12647982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for lung cancer: practice and promise.
    Vattemi E; Claudio PP
    Ann Ital Chir; 2004; 75(3):279-89. PubMed ID: 15605515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for lung cancer.
    Toloza EM; Morse MA; Lyerly HK
    J Cell Biochem; 2006 Sep; 99(1):1-22. PubMed ID: 16767697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and lung cancer: a review.
    Shivapurkar N; Reddy J; Chaudhary PM; Gazdar AF
    J Cell Biochem; 2003 Apr; 88(5):885-98. PubMed ID: 12616528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targets and approaches in advanced prostate cancer.
    Hadaschik BA; Sowery RD; Gleave ME
    Curr Opin Urol; 2007 May; 17(3):182-7. PubMed ID: 17414516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic.
    Dean EJ; Ranson M; Blackhall F; Holt SV; Dive C
    Cancer Treat Rev; 2007 Apr; 33(2):203-12. PubMed ID: 17210228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of lung cancer.
    Daniel JC; Smythe WR
    Semin Surg Oncol; 2003; 21(3):196-204. PubMed ID: 14508853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel targets in gastric and esophageal cancer.
    Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
    Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitargeted inhibitors in lung cancer: new clinical data.
    Bar J; Herbst RS; Onn A
    Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
    Wallerand H; Reiter RR; Ravaud A
    Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier.
    Sangha R; Lara PN; Mack PC; Gandara DR
    Curr Opin Oncol; 2009 Mar; 21(2):116-23. PubMed ID: 19532012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of lung cancer with implications for new therapies.
    Aberle MF; McLeskey SW
    Oncol Nurs Forum; 2003; 30(2):273-80. PubMed ID: 12692661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of new targeted therapies in small-cell lung cancer.
    Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.